78 related articles for article (PubMed ID: 8593966)
1. Blood platelet activation and membrane glycoprotein changes during extracorporeal life support (ECLS). In vitro studies.
Mellgren K; Friberg LG; Hedner T; Mellgren G; Wadenvik H
Int J Artif Organs; 1995 Jun; 18(6):315-21. PubMed ID: 8593966
[TBL] [Abstract][Full Text] [Related]
2. Induced cell trauma during in vitro perfusion: a comparison between two different perfusion systems.
Skogby M; Mellgren K; Adrian K; Friberg LG; Chevalier JY; Mellgren G
Artif Organs; 1998 Dec; 22(12):1045-51. PubMed ID: 9876097
[TBL] [Abstract][Full Text] [Related]
3. The effect of epoprostenol on platelet activation and consumption during experimental extracorporeal perfusion.
Skogby M; Adrian K; Friberg L; Mellgren K
Artif Organs; 1999 Nov; 23(11):984-7. PubMed ID: 10564302
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of plasma coagulation and platelet activation during experimental long-term perfusion.
Skogby M; Friberg LG; Adrian K; Mellgren K
Scand Cardiovasc J; 2003 Sep; 37(4):222-8. PubMed ID: 12944211
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide diffusion across membrane lungs protects platelets during simulated extracorporeal circulation.
Keh D; Gerlach M; Kürer I; Spielmann S; Kerner T; Busch T; Hansen R; Falke K; Gerlach H
Eur J Clin Invest; 1999 Apr; 29(4):344-50. PubMed ID: 10231347
[TBL] [Abstract][Full Text] [Related]
6. Effect of nitric oxide gas on platelets during open heart operations.
Mellgren K; Mellgren G; Lundin S; Wennmalm A; Wadenvik H
Ann Thorac Surg; 1998 May; 65(5):1335-41. PubMed ID: 9594863
[TBL] [Abstract][Full Text] [Related]
7. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H
Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion.
Mellgren K; Friberg LG; Mellgren G; Hedner T; Wennmalm A; Wadenvik H
Ann Thorac Surg; 1996 Apr; 61(4):1194-8. PubMed ID: 8607682
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with Nikkiso centrifugal pumps for extracorporeal circulation.
Onoda K; Kondo C; Mizumoto T; Kusagawa H; Katayama Y; Hayashi T; Komada T; Hirano R; Miyamura T; Tanaka J
Artif Organs; 1994 Sep; 18(9):706-10. PubMed ID: 7998891
[TBL] [Abstract][Full Text] [Related]
10. The effect of albumin priming solution on platelet activation during experimental long-term perfusion.
Adrian K; Mellgren K; Skogby M; Friberg LG; Mellgren G; Wadenvik H
Perfusion; 1998 May; 13(3):187-91. PubMed ID: 9638716
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation and problems on platelet function tests].
Kume S
Nihon Rinsho; 1997 Mar; 55 Suppl 1():94-101. PubMed ID: 9097565
[No Abstract] [Full Text] [Related]
13. Platelet storage results in a redistribution of glycoprotein Ib molecules. Evidence for a large intraplatelet pool of glycoprotein Ib.
Michelson AD; Adelman B; Barnard MR; Carroll E; Handin RI
J Clin Invest; 1988 Jun; 81(6):1734-40. PubMed ID: 3384948
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
15. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
[TBL] [Abstract][Full Text] [Related]
16. Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins.
Kawahito K; Mohara J; Misawa Y; Fuse K
Artif Organs; 1997 Oct; 21(10):1105-9. PubMed ID: 9335369
[TBL] [Abstract][Full Text] [Related]
17. [Detection of platelet activation].
Matsuno K
Rinsho Byori; 1995 May; 43(5):432-7. PubMed ID: 7540228
[TBL] [Abstract][Full Text] [Related]
18. Influence of hemofiltration on plasma cytokine levels and platelet activation during extra corporeal membrane oxygenation.
Skogby M; Adrian K; Friberg LG; Mellgren G; Mellgren K
Scand Cardiovasc J; 2000 Jun; 34(3):315-20. PubMed ID: 10935780
[TBL] [Abstract][Full Text] [Related]
19. Quality of platelet concentrates irradiated with UVB light: effect of UV dose and dose rate on glycocalicin release and correlation with other markers of the platelet storage lesion.
Bessos H; Murphy WG; Robertson A; Vickers M; Seghatchian MJ; Tandy NP; Cutts M; Pamphilon DH
Transfus Med; 1993 Jun; 3(2):115-21. PubMed ID: 8374699
[TBL] [Abstract][Full Text] [Related]
20. Reoperation and the centrifugal pump?
Jakob H; Hafner G; Iversen S; Hake U; Thelemann C; Prellwitz W; Oelert H
Eur J Cardiothorac Surg; 1992; 6 Suppl 1():S59-63. PubMed ID: 1389281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
